Mastercard reports 20% rise in Q3 2025 net income
The company posted net revenue of $8.6bn for Q3 2025, a 17% increase from the same quarter in 2024.
Stay informed with the latest insights, analysis, and news from the world of finance and investing.
The company posted net revenue of $8.6bn for Q3 2025, a 17% increase from the same quarter in 2024.
Dexcom's solid third-quarter report was overshadowed Friday by its "surprisingly cautious" outlook, and Dexcom stock tumbled.
Get insights on Trump's Asia tour: peace deals, trade truces, strategic US-Asia partnerships, and bullish outlook for rare-earth supply chains.
Big stock market winners tend to look a lot alike ahead of a major price again. And the flat base is often the launching pad.
Amgen (NASDAQ:AMGN) today announced that new data from its cardiovascular portfolio, including late-breaking results from the Phase 3 VESALIUS-CV clinical trial of Repatha® (evolocumab), will be presented at the American Heart Association Scientific Sessions taking place November 7-10, 2025, in New Orleans, LA.
Engine Designed for Next-Gen CCA-type AircraftSAN DIEGO, Oct. 31, 2025 (GLOBE NEWSWIRE) -- Kratos Defense & Security Solutions, Inc. (Nasdaq: KTOS), a technology company in Defense, National Security and Global Markets, and GE Aerospace (NYSE:GE) today announced the successful completion of altitude testing. The companies also conducted durability and limits testing on its GEK800 engine designed to power the next generation of affordable unmanned aerial systems and CCA-type aircraft. The testing
Bretton Capital Management, an investment management company, released the “Bretton Fund” third-quarter 2025 investor letter. A copy of the letter can be downloaded here. The fund returned 8.21% compared to 8.12% for the S&P 500 Index. In addition, you can check the fund’s top 5 holdings to determine its best picks for 2025. In its […]
Investing.com -- JPMorgan said the current market environment differs markedly from the late 1990s tech bubble in five key ways, citing stronger corporate balance sheets, more moderate equity positioning, and less exuberant capital expenditure.
Revenue for AWS, Amazon’s closely watched cloud unit, was $33 billion versus a $32.5 billion analyst estimate.
STORY: :: Novo Nordisk Novo Nordisk has almost completed notifying employees impacted by the drugmaker's 9,000 job cuts.That’s according to a LinkedIn post by CEO Mike Doustdar Friday. As jobs were slashed globally, he added that the pace of informing people varied according to local laws. It’s part of Doustdar’s restructuring drive which he launched last month. And comes as Novo faces heated competition in the United States, the world's biggest drug market, against rival Eli Lilly.The $150 billion weight-loss drug market is booming and Novo’s setting its sights on newer heights. :: Pfizer The Danish pharma giant and another major rival Pfizer are in a bidding war over obesity biotech Metsera’s hottest experimental treatments. The drugmakers are vying for access to its once-monthly GLP-1 injectable.Current popular injectables, including Novo’s Wegovy and Eli Lilly’s Zepbound, are weekly shots. Metsera is one of several companies developing experimental weight-loss drugs.The move signals an aggressive turn by Novo Nordisk a week after the ousting of most of the company's board.That was over concerns it was not moving fast enough in the obesity market.